Provider: NIHR Journals Library
Content:text/plain; charset="UTF-8"
TY  - JOUR
LB  - 1.
AU  - Tullett, J
AU  - Murray, E
AU  - Nichols, L
AU  - Holder, R
AU  - Lester, W
AU  - Rose, P
TI  - Trial protocol: a randomised controlled trial of extended anticoagulation treatment versus routine anticoagulation treatment for the prevention of recurrent VTE and post thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (The ExACT Study)
J2  - BMC Cardiovasc Disord
PY  - 2013
VL  - 13
SP  - 16
UR  - https://doi.org/10.1186/1471-2261-13-16
ER  - 
TY  - JOUR
LB  - 2.
AU  - McFarland, L
AU  - Ward, A
AU  - Greenfield, S
AU  - Murray, E
AU  - Heneghan, C
AU  - Harrison, S
AU  - Fitzmaurice, D
TI  - ExPeKT – exploring prevention and knowledge of venous thromboembolism: a two-stage, mixed-method study protocol
J2  - BMJ Open
PY  - 2013
VL  - 3
SP  - e002766
UR  - https://doi.org/10.1136/bmjopen-2013-002766
ER  - 
TY  - GEN
LB  - 3.
AU  - All-Party Parliamentary Thrombosis Group
TI  - Addressing the Challenges, Maintaining the Momentum: An Analysis of the Progress to Date and a Vision for 2015 and Beyond, October 2015
CY  - London
PB  - The Stationery Office
PY  - 2012
ER  - 
TY  - JOUR
LB  - 4.
AU  - Januel, JM
AU  - Chen, G
AU  - Ruffieux, C
AU  - Quan, H
AU  - Douketis, JD
AU  - Crowther, MA
TI  - Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: a systematic review
J2  - JAMA
PY  - 2012
VL  - 307
SP  - 294
EP  - 303
UR  - https://doi.org/10.1001/jama.2011.2029
ER  - 
TY  - JOUR
LB  - 5.
AU  - Cohen, AT
AU  - Tapson, VF
AU  - Bergmann, JF
AU  - Goldhaber, SZ
AU  - Kakkar, AK
AU  - Deslandes, B
TI  - Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
J2  - Lancet
PY  - 2008
VL  - 371
SP  - 387
EP  - 394
UR  - https://doi.org/10.1016/S0140-6736(08)60202-0
ER  - 
TY  - JOUR
LB  - 6.
AU  - Leizorovicz, A
AU  - Cohen, AT
AU  - Turpie, AG
AU  - Olsson, CG
AU  - Vaitkus, PT
AU  - Goldhaber, SZ
AU  - PREVENT Medical Thromboprophylaxis Study Group
TI  - Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients
J2  - Circulation
PY  - 2004
VL  - 110
SP  - 874
EP  - 879
UR  - https://doi.org/10.1161/01.CIR.0000138928.83266.24
ER  - 
TY  - ELEC
LB  - 7.
AU  - NICE
TI  - Venous Thromboembolism in Over 16s: Reducing the Risk of Hospital-acquired Deep Vein Thrombosis or Pulmonary Embolism
UR  - www.nice.org.uk/guidance/NG89
M1  - 16 October 2019
ER  - 
TY  - JOUR
LB  - 8.
AU  - Huo, MH
AU  - Muntz, J
TI  - Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review
J2  - Clin Ther
PY  - 2009
VL  - 31
SP  - 1129
EP  - 1141
UR  - https://doi.org/10.1016/j.clinthera.2009.06.002
ER  - 
TY  - JOUR
LB  - 9.
AU  - Sarasin, FP
AU  - Bounameaux, H
TI  - Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis
J2  - Thromb Haemost
PY  - 2002
VL  - 87
SP  - 586
EP  - 592
UR  - https://doi.org/10.1055/s-0037-1613053
ER  - 
TY  - JOUR
LB  - 10.
AU  - Sweetland, S
AU  - Green, J
AU  - Liu, B
AU  - Berrington de González, A
AU  - Canonico, M
AU  - Reeves, G
TI  - Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study
J2  - BMJ
PY  - 2009
VL  - 339
SP  - b4583
UR  - https://doi.org/10.1136/bmj.b4583
ER  - 
TY  - JOUR
LB  - 11.
AU  - Shrivastava, S
AU  - Ridker, PM
AU  - Glynn, RJ
AU  - Goldhaber, SZ
AU  - Moll, S
AU  - Bounameaux, H
TI  - D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism
J2  - J Thromb Haemost
PY  - 2006
VL  - 4
SP  - 1208
EP  - 1214
UR  - https://doi.org/10.1111/j.1538-7836.2006.01935.x
ER  - 
TY  - BOOK
LB  - 12.
AU  - Kind, P
AU  - Hardman, G
AU  - Macran, S
TI  - UK Population Norms for EQ-5D
CY  - York
PB  - Centre for Health Economics, University of York
PY  - 1999
ER  - 
TY  - GEN
LB  - 13.
AU  - National Institute for Health and Care Excellence
TI  - Guide to the Methods of Technology Appraisal
CY  - London
PB  - NICE
PY  - 2013
ER  - 
TY  - JOUR
LB  - 14.
AU  - Rodger, MA
AU  - Scarvelis, D
AU  - Kahn, SR
AU  - Wells, PS
AU  - Anderson, DA
AU  - Chagnon, I
TI  - Long-term risk of venous thrombosis after stopping anticoagulants for a first unprovoked event: a multi-national cohort
J2  - Thromb Res
PY  - 2016
VL  - 356
SP  - 152
EP  - 158
UR  - https://doi.org/10.1016/j.thromres.2016.03.028
ER  - 
TY  - JOUR
LB  - 15.
AU  - Altman, DG
AU  - Doré, CJ
TI  - Randomisation and baseline comparisons in clinical trials
J2  - Lancet
PY  - 1990
VL  - 335
SP  - 149
EP  - 153
UR  - https://doi.org/10.1016/0140-6736(90)90014-V
ER  - 
TY  - JOUR
LB  - 16.
AU  - Amin, A
AU  - Spyropoulos, AC
AU  - Dobesh, P
AU  - Shorr, A
AU  - Hussein, M
AU  - Mozaffari, E
AU  - Benner, JS
TI  - Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start)
J2  - J Thromb Thrombolysis
PY  - 2010
VL  - 29
SP  - 326
EP  - 339
UR  - https://doi.org/10.1007/s11239-009-0361-z
ER  - 
TY  - ELEC
LB  - 17.
AU  - The All-Party Parliamentary Thrombosis Group
UR  - http://apptg.org.uk/
M1  - February 2020
ER  - 
TY  - BOOK
LB  - 18.
AU  - Curtis, L
TI  - Unit Costs of Health and Social Care 2014
CY  - Canterbury
PB  - PSSRU, University of Kent
PY  - 2014
ER  - 
TY  - JOUR
LB  - 19.
AU  - Jowett, S
AU  - Bryan, S
AU  - Murray, E
AU  - McCahon, D
AU  - Raftery, J
AU  - Hobbs, FD
AU  - Fitzmaurice, D
TI  - Patient self-management of anticoagulation therapy: a trial-based cost-effectiveness analysis
J2  - Br J Haematol
PY  - 2006
VL  - 134
SP  - 632
EP  - 639
UR  - https://doi.org/10.1111/j.1365-2141.2006.06243.x
ER  - 
TY  - ELEC
LB  - 20.
UR  - www.e-dendrite.com/files/13/file/Pages%20from%20VERITY%202007.pdf
M1  - 18 October 2016
ER  - 
TY  - JOUR
LB  - 21.
AU  - Agnelli, G
AU  - Buller, HR
AU  - Cohen, A
AU  - Curto, M
AU  - Gallus, AS
AU  - Johnson, M
TI  - Apixaban for extended treatment of venous thromboembolism
J2  - N Engl J Med
PY  - 2013
VL  - 368
SP  - 699
EP  - 708
UR  - https://doi.org/10.1056/NEJMoa1207541
ER  - 
TY  - JOUR
LB  - 22.
AU  - Kearon, C
AU  - Parpia, S
AU  - Spencer, FA
AU  - Schulman, S
AU  - Stevens, SM
AU  - Shah, V
TI  - Long-term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to D-dimer results: a cohort study
J2  - J Thrombosis Hemostasis
PY  - 2019
VL  - 17
SP  - 1144
EP  - 1152
UR  - https://doi.org/10.1111/jth.14458
ER  - 
TY  - JOUR
LB  - 23.
AU  - McFarland, L
AU  - Murray, E
AU  - Harrison, S
AU  - Heneghan, C
AU  - Ward, A
AU  - Fitzmaurice, D
AU  - Greenfield, S
TI  - Current practice of venous thromboembolism prevention in acute trusts: a qualitative study
J2  - BMJ Open
PY  - 2014
VL  - 4
SP  - e005074
UR  - https://doi.org/10.1136/bmjopen-2014-005074
ER  - 
TY  - JOUR
LB  - 24.
AU  - Apenteng, PN
AU  - Fitzmaurice, D
AU  - Litchfield, I
AU  - Harrison, S
AU  - Heneghan, C
AU  - Ward, A
AU  - Greenfield, S
TI  - Patients’ perceptions and experiences of the prevention of hospital-acquired thrombosis: a qualitative study
J2  - BMJ Open
PY  - 2016
VL  - 6
SP  - e013839
UR  - https://doi.org/10.1136/bmjopen-2016-013839
ER  - 
TY  - JOUR
LB  - 25.
AU  - Litchfield, I
AU  - Fitzmaurice, D
AU  - Apenteng, P
AU  - Harrison, S
AU  - Heneghan, C
AU  - Ward, A
AU  - Greenfield, S
TI  - Prevention of hospital-acquired thrombosis from a primary care perspective: a qualitative study
J2  - Br J Gen Pract
PY  - 2016
VL  - 66
SP  - e593
EP  - e602
UR  - https://doi.org/10.3399/bjgp16X685693
ER  - 
TY  - GEN
LB  - 26.
AU  - NICE
TI  - Rivaroxaban for the Treatment of Deep Vein Thrombosis and Prevention of Recurrent Deep Vein Thrombosis and Pulmonary Embolism (NICE Technology Appraisal TA261)
CY  - London
PB  - NICE
PY  - 2012
ER  - 
TY  - GEN
LB  - 27.
AU  - NHS
TI  - Commissioning for Quality and Innovation
PB  - NHS
UR  - www.england.nhs.uk/nhs-standard-contract/cquin/
Y2  - 23 April 2020
ER  - 
TY  - JOUR
LB  - 28.
AU  - Cohen, AT
AU  - Agnelli, G
AU  - Anderson, FA
AU  - Arcelus, JI
AU  - Berggvist, D
AU  - Brecht, JG
TI  - Venous thromboembolism (VTE) in Europe
J2  - Thromb Haemost
PY  - 2007
VL  - 98
SP  - 756
EP  - 764
UR  - https://doi.org/10.1160/TH07-03-0212
ER  - 
TY  - JOUR
LB  - 29.
AU  - Ageno, W
AU  - Spyropoulos, AC
AU  - Turpie, AG
TI  - Role of new anticoagulants for the prevention of venous thromboembolism after major orthopaedic surgery and in hospitalised acutely ill medical patients
J2  - Thromb Haemost
PY  - 2012
VL  - 107
SP  - 1027
EP  - 1034
UR  - https://doi.org/10.1160/TH11-11-0787
ER  - 
TY  - JOUR
LB  - 30.
AU  - Geerts, WH
AU  - Bergqvist, D
AU  - Pineo, GF
AU  - Heit, JA
AU  - Samama, CM
AU  - Lassen, MR
AU  - Colwell, CW
TI  - Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
J2  - Chest
PY  - 2008
VL  - 133
IS  - Suppl. 6
SP  - 381
EP  - 453
UR  - https://doi.org/10.1378/chest.08-0656
ER  - 
TY  - JOUR
LB  - 31.
AU  - Ageno, W
AU  - Gallus, AS
AU  - Wittkowsky, A
AU  - Crowther, M
AU  - Hylek, EM
AU  - Palareti, G
TI  - Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
J2  - Chest
PY  - 2012
VL  - 141
IS  - Suppl. 2
SP  - e44
EP  - e88
UR  - https://doi.org/10.1378/chest.11-2292
ER  - 
TY  - JOUR
LB  - 32.
AU  - Heit, JA
AU  - Silverstein, MD
AU  - Mohr, DN
AU  - Petterson, TM
AU  - O’Fallon, WM
AU  - Melton, LJ
TI  - Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study
J2  - Arch Intern Med
PY  - 2000
VL  - 160
SP  - 809
EP  - 815
UR  - https://doi.org/10.1001/archinte.160.6.809
ER  - 
TY  - JOUR
LB  - 33.
AU  - Khorana, AA
TI  - Cancer and thrombosis: implications of published guidelines for clinical practice
J2  - Ann Oncol
PY  - 2009
VL  - 20
SP  - 1619
EP  - 1630
UR  - https://doi.org/10.1093/annonc/mdp068
ER  - 
TY  - JOUR
LB  - 34.
AU  - Shen, VS
AU  - Pollak, EW
TI  - Fatal pulmonary embolism in cancer patients: is heparin prophylaxis justified?
J2  - Southern Med J
PY  - 1980
VL  - 73
SP  - 841
EP  - 843
UR  - https://doi.org/10.1097/00007611-198007000-00005
ER  - 
TY  - JOUR
LB  - 35.
AU  - Fogelholm, R
AU  - Murros, K
AU  - Rissanen, A
AU  - Avikainen, S
TI  - Long term survival after primary intracerebral haemorrhage: a retrospective population based study
J2  - J Neurol Neurosurg Psychiatry
PY  - 2005
VL  - 76
SP  - 1534
EP  - 1538
UR  - https://doi.org/10.1136/jnnp.2004.055145
ER  - 
TY  - JOUR
LB  - 36.
AU  - Spencer, FA
AU  - Emery, C
AU  - Lessard, D
AU  - Goldberg, RJ
TI  - Worcester Venous Thromboembolism Study. Upper extremity deep vein thrombosis: a community-based perspective
J2  - Am J Med
PY  - 2007
VL  - 120
SP  - 678
EP  - 684
UR  - https://doi.org/10.1016/j.amjmed.2006.06.046
ER  - 
TY  - JOUR
LB  - 37.
AU  - Laporte, S
AU  - Mismetti, P
AU  - Décousus, H
AU  - Uresandi, F
AU  - Otero, R
AU  - Lobo, JL
TI  - Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry
J2  - Circulation
PY  - 2008
VL  - 117
SP  - 1711
EP  - 1716
UR  - https://doi.org/10.1161/CIRCULATIONAHA.107.726232
ER  - 
TY  - JOUR
LB  - 38.
AU  - Warwick, D
AU  - Friedman, RJ
AU  - Agnelli, G
AU  - Gil-Garay, E
AU  - Johnson, K
AU  - FitzGerald, G
AU  - Turibio, FM
TI  - Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry
J2  - J Bone Joint Surg Br
PY  - 2007
VL  - 89
SP  - 799
EP  - 807
UR  - https://doi.org/10.1302/0301-620X.89B6.18844
ER  - 
TY  - JOUR
LB  - 39.
AU  - Caprini, JA
AU  - Hyers, TM
TI  - Compliance with antithrombotic guidelines
J2  - Manag Care
PY  - 2006
VL  - 15
SP  - 49
EP  - 50
SP  - 53
EP  - 60, 66
ER  - 
TY  - JOUR
LB  - 40.
AU  - Sterne, JA
AU  - Bodalia, PN
AU  - Bryden, PA
AU  - Davies, PA
AU  - López-López, JA
AU  - Okoli, GN
TI  - Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis
J2  - Health Technol Assess
PY  - 2017
VL  - 21
IS  - 9
UR  - https://doi.org/10.3310/hta21090
ER  - 
TY  - ELEC
LB  - 41.
AU  - NICE
TI  - Venous Thromboembolism: Reducing the Risk for Patients in Hospital
UR  - www.nice.org.uk/Guidance/CG92
M1  - March 2020
ER  - 
TY  - JOUR
LB  - 42.
AU  - Scannapieco, G
AU  - Ageno, W
AU  - Airoldi, A
AU  - Bonizzoni, E
AU  - Campanini, M
AU  - Gussoni, G
TI  - Incidence and predictors of venous thromboembolism in post-acute care patients. A prospective cohort study
J2  - Thromb Haemost
PY  - 2010
VL  - 104
SP  - 734
EP  - 740
UR  - https://doi.org/10.1160/TH10-03-0169
ER  - 
TY  - ELEC
LB  - 43.
AU  - NHS Choices
TI  - Improving Health, Improving Lives
PY  - 2011
UR  - www.nhs.uk/about-the-nhs-website/professionals/developments/documents/annual-report/annual_report_2011_digital.pdf
M1  - March 2020
ER  - 
TY  - JOUR
LB  - 44.
AU  - Glaser, BG
TI  - The constant comparative method of qualitative analysis
J2  - Social Problems
PY  - 1965
VL  - 12
SP  - 436
EP  - 445
UR  - https://doi.org/10.2307/798843
ER  - 
TY  - ELEC
LB  - 45.
AU  - House of Commons Health Committee
TI  - The Prevention of Venous Thromboembolism in Hospitalised Patients. Second Report of Session 2004–05
UR  - https://publications.parliament.uk/pa/cm200405/cmselect/cmhealth/99/99.pdf
M1  - March 2020
ER  - 
TY  - JOUR
LB  - 46.
AU  - Monahan, M
AU  - Ensor, J
AU  - Moore, D
AU  - Fitzmaurice, D
AU  - Jowett, S
TI  - Economic evaluation of strategies for restarting anticoagulation therapy with warfarin based on Venous Thromboembolism (VTE) risk after an index unprovoked VTE event
J2  - J Thrombosis Haemostasis
PY  - 2017
VL  - 15
SP  - 1591
EP  - 1600
UR  - https://doi.org/10.1111/jth.13739
ER  - 
TY  - ELEC
LB  - 47.
AU  - Department of Health and Social Care
TI  - NHS Reference Costs 2012/13
UR  - www.gov.uk/government/publications/nhs-reference-costs-2012-to-2013
M1  - March 2020
ER  - 
TY  - JOUR
LB  - 48.
AU  - Appleby, J
AU  - Devlin, N
AU  - Parkin, D
TI  - NICE’s cost effectiveness threshold
J2  - BMJ
PY  - 2007
VL  - 335
SP  - 358
EP  - 359
UR  - https://doi.org/10.1136/bmj.39308.560069.BE
ER  - 
TY  - ELEC
LB  - 49.
AU  - NICE
TI  - Atrial Fibrillation: Medicines to Help Reduce your Risk of a Stroke – What are the Options?
UR  - www.nice.org.uk/guidance/cg180/resources/cg180-atrial-fibrillation-update-patient-decision-aid-243734797
M1  - 14 April 2018
ER  - 
TY  - JOUR
LB  - 50.
AU  - Kahn, SR
AU  - Lamping, DL
AU  - Ducruet, T
AU  - Arsenault, L
AU  - Miron, MJ
AU  - Roussin, A
TI  - VEINES-QOL/Sym questionnaire was a reliable and valid disease-specific quality of life measure for deep venous thrombosis
J2  - J Clin Epidemiol
PY  - 2006
VL  - 59
SP  - 1049
EP  - 1056
UR  - https://doi.org/10.1016/j.jclinepi.2005.10.016
ER  - 
TY  - JOUR
LB  - 51.
AU  - Kahn, SR
TI  - Measurement properties of the Villalta scale to define and classify the severity of the post-thrombotic syndrome
J2  - J Thromb Haemost
PY  - 2009
VL  - 7
SP  - 884
EP  - 888
UR  - https://doi.org/10.1111/j.1538-7836.2009.03339.x
ER  - 
TY  - JOUR
LB  - 52.
AU  - Palareti, G
AU  - Legnani, C
AU  - Cosmi, B
AU  - Guazzaloca, G
AU  - Pancani, C
AU  - Coccheri, S
TI  - Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped
J2  - Thromb Haemost
PY  - 2002
VL  - 87
SP  - 7
EP  - 12
UR  - https://doi.org/10.1055/s-0037-1612936
ER  - 
TY  - JOUR
LB  - 53.
AU  - Baglin, T
AU  - Palmer, CR
AU  - Luddington, R
AU  - Baglin, C
TI  - Unprovoked recurrent venous thrombosis: prediction by D-dimer and clinical risk factors
J2  - J Thromb Haemost
VL  - 6
SP  - 577
EP  - 582
ER  - 
TY  - JOUR
LB  - 54.
AU  - Royston, P
AU  - Sauerbrei, W
TI  - A new approach to modelling interactions between treatment and continuous covariates in clinical trials by using fractional polynomials
J2  - Stat Med
PY  - 2004
VL  - 23
SP  - 2509
EP  - 2525
UR  - https://doi.org/10.1002/sim.1815
ER  - 
TY  - GEN
LB  - 55.
AU  - Joint Formulary Committee
TI  - British National Formulary
ET  - 65
CY  - London
PB  - BMJ Group and Pharmaceutical Press
PY  - 2013
ER  - 
TY  - ELEC
LB  - 56.
UR  - www.solent.nhs.uk/_store/documents/woundformularyfeb13finalupdateapril2013.pdf
M1  - 18 October 2016
ER  - 
TY  - BOOK
LB  - 57.
AU  - Curtis, L
TI  - Unit Costs of Health and Social Care 2013
CY  - Canterbury
PB  - PSSRU, University of Kent
PY  - 2013
ER  - 
TY  - JOUR
LB  - 58.
AU  - Dolan, P
TI  - Modelling valuations for EuroQol health states
J2  - Med Care
PY  - 1997
VL  - 11
SP  - 1095
EP  - 1108
UR  - https://doi.org/10.1097/00005650-199711000-00002
ER  - 
TY  - BOOK
LB  - 59.
AU  - Rubin, DB
TI  - Multiple Imputation for Nonresponse in Surveys
CY  - New York, NY
PB  - John Wiley & Sons
PY  - 1987
UR  - https://doi.org/10.1002/9780470316696
ER  - 
TY  - JOUR
LB  - 60.
AU  - Manca, A
AU  - Hawkins, N
AU  - Sculpher, MJ
TI  - Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility
J2  - Health Econ
PY  - 2005
VL  - 14
SP  - 487
EP  - 496
UR  - https://doi.org/10.1002/hec.944
ER  - 
TY  - GEN
LB  - 61.
AU  - Office for National Statistics
TI  - National Life Tables, England & Wales, 1980–82 to 2010–12
CY  - Newport
PB  - Office for National Statistics
PY  - 2013
ER  - 
TY  - JOUR
LB  - 62.
AU  - Chitsike, RS
AU  - Rodger, MA
AU  - Kovacs, MJ
AU  - Betancourt, MT
AU  - Wells, PS
AU  - Anderson, DR
TI  - Risk of post-thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study
J2  - J Thromb Haemost
PY  - 2012
VL  - 10
SP  - 2039
EP  - 2044
UR  - https://doi.org/10.1111/j.1538-7836.2012.04872.x
ER  - 
TY  - JOUR
LB  - 63.
AU  - Luengo-Fernandez, R
AU  - Gray, AM
AU  - Rothwell, PM
AU  - Oxford Vascular Study
TI  - A population-based study of hospital care costs during 5 years after transient ischemic attack and stroke
J2  - Stroke
PY  - 2012
VL  - 43
SP  - 3343
EP  - 3351
UR  - https://doi.org/10.1161/STROKEAHA.112.667204
ER  - 
TY  - BOOK
LB  - 64.
AU  - Kind, P
AU  - Hardman, G
AU  - Macran, S
TI  - UK Population Norms for EQ-5D
CY  - York
PB  - Centre for Health Economics, University of York
PY  - 1999
ER  - 
TY  - JOUR
LB  - 65.
AU  - Locadia, M
AU  - Bossuyt, PM
AU  - Stalmeier, PF
AU  - Sprangers, MA
AU  - van Dongen, CJ
AU  - Middeldorp, S
TI  - Treatment of venous thromboembolism with vitamin K antagonists: patients’ health state valuations and treatment preferences
J2  - Thromb Haemost
PY  - 2004
VL  - 92
SP  - 1336
EP  - 1341
UR  - https://doi.org/10.1160/TH04-02-0075
ER  - 
TY  - JOUR
LB  - 66.
AU  - Ensor, J
AU  - Riley, RD
AU  - Jowett, S
AU  - Monahan, M
AU  - Snell, KIe
AU  - Bayliss, S
TI  - Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism: systematic review, prognostic model and clinical decision rule, and economic evaluation
J2  - Health Technol Assess
PY  - 2016
VL  - 20
IS  - 12
UR  - https://doi.org/10.3310/hta20120
ER  - 
TY  - JOUR
LB  - 67.
AU  - Douketis, J
AU  - Tosetto, A
AU  - Marcucci, M
AU  - Baglin, T
AU  - Cushman, M
AU  - Eichinger, S
TI  - Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism
J2  - Ann Intern Med
PY  - 2010
VL  - 153
SP  - 523
EP  - 531
UR  - https://doi.org/10.7326/0003-4819-153-8-201010190-00009
ER  - 
TY  - BOOK
LB  - 68.
AU  - Curtis, L
AU  - Burns, A
TI  - Unit Costs of Health and Social Care 2017
CY  - Canterbury
PB  - PSSRU, University of Kent
PY  - 2017
ER  - 
TY  - JOUR
LB  - 69.
AU  - Schulman, S
AU  - Kearon, C
AU  - Kakkar, AK
AU  - Mismetti, P
AU  - Schellong, S
AU  - Eriksson, H
TI  - Dabigatran versus warfarin in the treatment of acute venous thromboembolism
J2  - N Engl J Med
PY  - 2009
VL  - 361
SP  - 2342
EP  - 2352
UR  - https://doi.org/10.1056/NEJMoa0906598
ER  - 
TY  - JOUR
LB  - 70.
AU  - Kearon, C
AU  - Gent, M
AU  - Hirsh, J
AU  - Weitz, J
AU  - Kovacs, MJ
AU  - Anderson, DR
TI  - A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism
J2  - N Engl J Med
PY  - 1999
VL  - 340
SP  - 901
EP  - 907
UR  - https://doi.org/10.1056/NEJM199903253401201
ER  - 
TY  - JOUR
LB  - 71.
AU  - Castellucci, LA
AU  - Le Gal, G
AU  - Rodger, MA
AU  - Carrier, M
TI  - Major bleeding during secondary prevention of venous thromboembolism in patients who have completed anticoagulation: a systematic review and meta-analysis
J2  - J Thromb Haemost
PY  - 2014
VL  - 12
SP  - 344
EP  - 348
UR  - https://doi.org/10.1111/jth.12501
ER  - 
TY  - JOUR
LB  - 72.
AU  - Eikelboom, JW
AU  - Wallentin, L
AU  - Connolly, SJ
AU  - Ezekowitz, M
AU  - Healey, JS
AU  - Oldgren, J
TI  - Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial
J2  - Circulation
PY  - 2011
VL  - 123
SP  - 2363
EP  - 2372
UR  - https://doi.org/10.1161/CIRCULATIONAHA.110.004747
ER  - 
TY  - GEN
LB  - 73.
AU  - EQ-5D
TI  - Population Norms
PB  - EQ-5D
UR  - https://euroqol.org/eq-5d-instruments/population-norms/
Y2  - 23 April 2020
ER  - 
TY  - GEN
LB  - 74.
AU  - Joint Formulary Committee
TI  - British National Formulary
ET  - 74
CY  - London
PB  - BMJ Group and Pharmaceutical Press
PY  - 2017
ER  - 
TY  - JOUR
LB  - 75.
AU  - Gage, BF
AU  - Cardinalli, AB
AU  - Owens, DK
TI  - The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life
J2  - Arch Intern Med
PY  - 1996
VL  - 156
SP  - 1829
EP  - 1836
UR  - https://doi.org/10.1001/archinte.1996.00440150083009
ER  -